DMK
IOVA icon

David M. Knott’s Iovance Biotherapeutics IOVA Stock Holding History

David M. Knott’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$99K Buy
+4,000
New +$94.3K 0.04% 120

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

David M. Knott's IOVA Position: Q3 2021 in Review

David M. Knott opened a new position in Iovance Biotherapeutics (IOVA) in Q3 2021: 4,000 shares worth $99K. The stake represents 0.04% of the portfolio and ranks #120 among its holdings.

243 funds tracked by Wall St. Rank hold IOVA as of Q3 2021.

  • David M. Knott held 4,000 shares of Iovance Biotherapeutics worth $99K as of Q3 2021.
  • Iovance Biotherapeutics was a new David M. Knott position in Q3 2021.
  • Iovance Biotherapeutics made up 0.04% of David M. Knott's portfolio in Q3 2021, its #120 holding.
  • 243 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.